Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) Short Interest Up 302.9% in August

Fisher & Paykel Healthcare Co. Limited (OTCMKTS:FSPKF) saw a large growth in short interest in August. As of August 31st, there was short interest totaling 31,081 shares, a growth of 302.9% from the August 15th total of 7,714 shares. Based on an average daily volume of 832 shares, the short-interest ratio is currently 37.4 days.

Fisher & Paykel Healthcare Price Performance

Shares of FSPKF opened at $25.79 on Friday. Fisher & Paykel Healthcare has a 52-week low of $19.01 and a 52-week high of $26.53. The stock has a fifty day simple moving average of $24.13 and a two-hundred day simple moving average of $23.06.

Wall Street Analysts Forecast Growth

Separately, Citigroup raised shares of Fisher & Paykel Healthcare to a “buy” rating in a research note on Thursday. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Fisher & Paykel Healthcare Company Profile

Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.

The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation.